IL1B and metabolic syndrome: Hyperinsulinemia and dyslipidemia can activate innate immune cells, leading to the release of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, which in turn promote endothelial dysfunction, vascular stiffness, and sodium retention—key hallmarks of hypertension [41,42].